News

Pfizer (PFE) and Bristol Myers (BMY) Launch Direct-to-Patient Eliquis Program

Pfizer, Inc. (NYSE:PFE) is one of the high-margin pharma stocks to buy now. Bristol-Myers Squibb Company (NYSE:BMY) and ...
The American Journal of Managed Care10d

Direct-to-Patient Apixaban Program Aims to Expand Access, Lower Out-of-Pocket Costs

Apixaban would still cost patients 9 times more through the Eliquis 360 Support program than with commercial insurance.

Pfizer (PFE) Expands Patient Access With Eliquis (Apixaban) Direct Purchase Program

Pfizer (PFE), in collaboration with Bristol Myers Squibb, has introduced a direct-to-patient option for Eliquis®, potentially ...
The Pharma Letter11d

BMS and Pfizer announce direct-to-patient Eliquis option

The Bristol Myers Squibb-Pfizer Alliance today announced a new direct-to-patient option for purchasing Eliquis (apixaban) via ...
Managed Healthcare Executive11d

BMS/Pfizer Offer Direct-to-Consumer Option for Eliquis

Following in the footsteps of other pharmaceutical companies, Bristol Myers Squibb and Pfizer are offering Eliquis for cash-paying patients at a discount of 40% off the list price.

Dear Doctor: Man’s worry over AFib meds is reasonable. But doing nothing is even more concerning

Many studies have shown that even though these medicines have risks, these risks are much lower than the risk of a stroke ...

Bristol Myers Squibb and Pfizer Announce Direct-to-Patient Eliquis® (apixaban) Option

The program will provide direct shipping to patients across all 50 states and Puerto Rico, offering an additional, simplified option for accessing Eliquis and full transparency into the associated ...